$BWAY 3 SEC Filings

Filed On	Filing
18 Mar 2026	Form 3: Hanlon Colleen, VP of Medical Affairs Holds 53,881 shares of Ordinary Shares
18 Mar 2026	Form 3: Boehm Amiram, Director Holds 18,750 shares of Ordinary Shares
18 Mar 2026	Form 3: Moiseyev Gilad, Chief Technology Officer Holds 52,500 shares of Ordinary Shares
18 Mar 2026	Form 3: Shulkin Jonathan K, Director Holds 536,494 shares of Ordinary Shares
18 Mar 2026	Form 3: Zangen Abraham, Director Holds 905,963 shares of Ordinary Shares
18 Mar 2026	Form 3: Mitrany Rayten Michal Ety, Director Holds 12,500 shares of Ordinary Shares
18 Mar 2026	Form 3: Zacut David, Director Holds 1,382,865 shares of Ordinary Shares
18 Mar 2026	Form 3: Marom Ido, Chief Financial Officer Holds 51,250 shares of Ordinary Shares
18 Mar 2026	Form 3: Sarid Karen, Director Holds 12,500 shares of Ordinary Shares
18 Mar 2026	Form 3: Lushi Avner, Director Holds 6,250 shares of Ordinary Shares
18 Mar 2026	Form 3: Rozenfeld Naomi, Chief Marketing Officer Holds 25,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Levy Hadar, Chief Executive Officer Holds 123,050 shares of Ordinary Shares
18 Mar 2026	Form 3: Roth Yiftach, Chief Scientist Holds 1,079,305 shares of Ordinary Shares

Comments